In summary, these findings advance our understanding of CD8+ T cell regulation, expose a new mechanism for modulating T cell activation and may lead to new therapeutic strategies for the treatment of cancer and other pathologies that may benefit from augmented T cell cytotoxicity. This evidence concerns the gene CD8A and cancer.